Pages in category: » All » Frozen Pages » Manuscript
See the complete listing of all pages in this category.
- Body-first subtype of Parkinson's disease with probable REM-sleep behaviour disorder is associated with non-motor dominant phenotype
- COBREXA.jl: constraint-based reconstruction and exascale analysis
- ChemPert: mapping between chemical perturbation and transcriptional response for noncancer cells
- Clustering and visualizing huge-scale cytometry datasets with GigaSOM.jl
- Concomitant AD and DLB pathologies shape subfield microglia responses in the hippocampus
- Dibac: Distribution-Based Analysis Of Cell Differentiation Identifies Mechanisms Of Cell Fate
- Functional meta-omics provide critical insights into long and short read assemblies
- Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A>G (p.T351A) or c.2067A>G (p.T610A) in the RHOT1 gene encoding Miro1
- Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.815G>A (p.R272Q) or c.1348C>T (p.R450C) in the RHOT1 gene encoding Miro1
- IMP: a pipeline for reproducible reference-independent integrated metagenomic and metatranscriptomic analyses
- Ice Recrystallization Inhibitors enable efficient cryopreservation of induced pluripotent stem cells: A functional and transcriptomic analysis
- Identification of tissue-specific and common methylation quantitative trait loci in healthy individuals using MAGAR
- Machine learning-assisted neurotoxicity prediction in human midbrain organoids
- Method optimization of skin biopsy-derived fibroblast culture for reprogramming into induced pluripotent stem cells (iPSCs)
- Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality
- Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-G2019S - associated gene expression
- Mitochondrial morphology provides a mechanism for energy buffering at synapses
- Modeling Parkinson's disease in midbrain-like organoids
- NORMAN Guidance on Suspect and Non-Target Screening in Environmental Monitoring
- PaFSe: a Parameter Free Segmentation Approach for 3D Fluorescent Images
- Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2‐Hydroxypropyl‐β‐Cyclodextrin Treatment
- Passive controlled flow for neuronal cell culture in 3D microfluidic devices
- Penalised regression with multiple sources of prior effects
- Per- and polyfluoroalkyl substances (PFAS) in PubChem: 7 million and growing
- Polarization of multi-agent gradient flows over manifolds with application to opinion dynamics
- Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease
- Retrograde procedural memory in Parkinson's disease: a cross-sectional, case-control study
- Retrospective Non-target Analysis to Support Regulatory Water Monitoring: From Masses of Interest to Recommendations via in silico workflows
- SMASCH: multi-appointment scheduling system for longitudinal clinical research studies
- Single cell transcriptomics of human iPSC differentiation dynamics reveal a core network of Parkinson’s disease
- Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids
- Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis
- Synaptic decline precedes dopaminergic neuronal loss in human midbrain organoids harboring a triplication of the SNCA gene
- The Parkinson's disease associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
- Trans-ancestry polygenic models for the prediction of LDL blood levels: an analysis in UK Biobank and Taiwan Biobank
- Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson’s Disease Point Mutation A30P